---
layout: post
title: "Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee; Postponement of Meeting"
date: 2026-02-05 19:01:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-23379
original_published: 2022-10-27 00:00:00 +0000
significance: 8.00
---

# Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee; Postponement of Meeting

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 27, 2022 00:00 UTC
**Document Number:** 2022-23379

## Summary

The Food and Drug Administration (FDA) is postponing the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee scheduled for November 18, 2022. Future meeting dates will be announced in the Federal Register.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/27/2022-23379/joint-meeting-of-the-nonprescription-drugs-advisory-committee-and-the-obstetrics-reproductive-and)
- API: https://www.federalregister.gov/api/v1/documents/2022-23379

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
